Tradestie Institutional Equity Comparison Engine
RGNX vs QURE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
QURE Overall Edge
QURE Captures Institutional Edge (3โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to uniQure N.V. (QURE) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, RGNX trades at N/M Forward P/E with -120.4% operating margin (-69.2% YoY revenue) versus QURE at 27.9x Forward P/E and -994.0% operating margin (+40.4% YoY). In options structure, RGNX sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro) against QURE sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
QURE
RGNX N/M vs QURE 27.9x Fwd P/E
Growth & Margin Winner
QURE
Op Margin -120.4% vs -994.0% ยท YoY -69.2% vs +40.4%
Momentum & Technical Winner
QURE
1Y -35.8% vs -27.4% ยท 52W Pos 19% vs 31%
Options & Structure Winner
Tie
BREAKDOWN (52nd %ile IV) vs BREAKDOWN (<1st %ile IV)
RGNX
NASDAQ
REGENXBIO Inc.
Biological Products, (No Disgnostic Substances)
$7.47
-2.23% 1D
Market Cap
$500.9M
1M Return
+7.87%
1Y Return
-35.82%
Forward P/E
N/M
Unified AI Score
45.3 / 100
HOLD
Tech 36.0
Fund 44.0
Flow 69.0
Mom 50.0
QURE
NASDAQ
uniQure N.V.
Pharmaceutical Preparations
$22.02
-7.52% 1D
Market Cap
$1.7B
1M Return
+1.1%
1Y Return
-27.42%
Forward P/E
27.9x
Unified AI Score
48.9 / 100
HOLD
Tech 42.0
Fund 55.0
Flow 69.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RGNX -35.82%
QURE -27.42%
Spread: +8.4 pp (QURE Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | RGNX Revenue | QURE Revenue | RGNX Op. Margin | QURE Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $220M | $10M | 40.3% | -781.9% | RGNX |
| FY2019 | $40M | $10M | -422.9% | -1663.8% | RGNX |
| FY2020 | $150M | $40M | -77.1% | -334.3% | RGNX |
| FY2021 | $470M | $520M | 34.0% | 59.3% | QURE |
| FY2022 | $110M | $110M | -233.2% | -134.4% | QURE |
| FY2023 | $90M | $20M | -297.1% | -1785.5% | RGNX |
| FY2024 | $80M | $30M | -280.0% | -679.6% | RGNX |
| FY2025 | $170M | $20M | -94.6% | -1151.4% | RGNX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RGNX | QURE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $500.9M | $1.7B | Larger Scale | QURE |
| Trailing P/E Ratio Valuation | N/M | 27.9x | Lower Multiple | QURE |
| Forward P/E Ratio Valuation | N/M | 27.9x | Lower Multiple | QURE |
| Revenue Growth (YoY) Growth | -69.2% | +40.4% | Higher Growth | QURE |
| Operating Margin (TTM) Profitability | -120.4% | -994.0% | Higher Margin | RGNX |
| Net Profit Margin Profitability | -113.9% | 0.0% | Higher Margin | QURE |
| Return on Equity (ROE) Capital Efficiency | -113.2% | -89.0% | Higher ROE | QURE |
| 52-Week Range Position Momentum | 19% ($5โ$16) | 31% ($9โ$52) | Stronger Trend | QURE |
| Beta / 30D Volatility Risk Regime | 1.81ฮฒ ยท 76% Vol | 0.80ฮฒ ยท 81% Vol | Lower Realized Risk | RGNX |
| Unified Institutional Score Composite Signal | 45.3 / 100 (HOLD) | 48.9 / 100 (HOLD) | Higher Composite | QURE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RGNX vs QURE Buy Guide
RGNX
BREAKDOWN
91d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
52nd %ile
IV Regime
Balanced (25thโ60th %ile)
QURE
BREAKDOWN
102d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RGNX nor QURE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.